Author:
Chopra Asmita,Zenati Mazen,Hogg Melissa E.,Zeh Herbert J.,Bartlett David L.,Bahary Nathan,Zureikat Amer H.,Beane Joal D.
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al. (eds). SEER Cancer Statistics Review, 1975–2016, National Cancer Institute. Bethesda, MD. Available at https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019.
2. Groot VP, Gemenetzis G, Blair AB, et al. Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(6):1154–62. https://doi.org/10.1097/SLA.0000000000002734.
3. Ghaneh P, Kleeff J, Halloran CM, et al. The impact of positive resection margins on survival and recurrence following resection and adjuvant chemotherapy for pancreatic ductal adenocarcinoma. Ann Surg. 2019;269(3):520–9. https://doi.org/10.1097/SLA.0000000000002557.
4. Nitta T, Nakamura T, Mitsuhashi T, et al. The impact of margin status determined by the one-millimeter rule on tumor recurrence and survival following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Surg Today. 2017;47(4):490–7. https://doi.org/10.1007/s00595-016-1420-7.
5. Kurlinkus B, Ahola R, Zwart E, et al. In the era of the leeds protocol: a systematic review and a meta-analysis on the effect of resection margins on survival among pancreatic ductal adenocarcinoma patients. Scand J Surg. 2020;109(1):11–7. https://doi.org/10.1177/1457496920911807.